US equities
|
NVDA
$239.66
▲+2.44%
SPCX
$169.38
▲+6.55%
MU
$1,060.78
▼-1.31%
TSLA
$380.89
▲+2.78%
SNDK
$1,688.69
▼-1.82%
MSFT
$528.42
▲+2.10%
INTC
$116.33
▼-2.51%
META
$742.58
▲+1.99%
NVDA
$239.66
▲+2.44%
SPCX
$169.38
▲+6.55%
MU
$1,060.78
▼-1.31%
TSLA
$380.89
▲+2.78%
SNDK
$1,688.69
▼-1.82%
MSFT
$528.42
▲+2.10%
INTC
$116.33
▼-2.51%
META
$742.58
▲+1.99%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Integra LifeSciences Holdings Corporation - Common Stock
(NQ:
IART
)
13.34
+0.66 (+5.17%)
Delayed Quote
Updated: 3:11 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Integra LifeSciences Holdings Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
3 Small-Cap Stocks We Approach with Caution
Today 0:35 EDT
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...
Via
StockStory
These stocks are moving in today's session
↗
October 02, 2026
Via
Chartmill
Why Integra LifeSciences (IART) Stock Is Nosediving
October 02, 2026
What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell 15.3% in the morning session after the company released preliminary t...
Via
StockStory
Friday's pre-market session: top gainers and losers
↗
October 02, 2026
Via
Chartmill
Integra LifeSciences (NASDAQ:IART) Surges Over 30% on Q2 Earnings Beat
↗
July 29, 2026
Via
Chartmill
1 of Wall Street’s Favorite Stocks with Impressive Fundamentals and 2 We Turn Down
September 28, 2026
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...
Via
StockStory
3 Reasons IART is Risky and 1 Stock to Buy Instead
September 10, 2026
What a time it’s been for Integra LifeSciences. In the past six months alone, the company’s stock price has increased by a massive 70.2%, reaching $16.26 per...
Via
StockStory
Topics
Bankruptcy
Q2 Earnings Outperformers: Integra LifeSciences (NASDAQ:IART) And The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
September 09, 2026
Let’s dig into the relative performance of Integra LifeSciences (NASDAQ:IART) and its peers as we unravel the now-completed Q2 surgical equipment & consumabl...
Via
StockStory
Topics
Artificial Intelligence
Economy
3 Cash-Producing Stocks That Fall Short
September 03, 2026
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via
StockStory
Topics
Firearms
3 Profitable Stocks We Think Twice About
August 24, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via
StockStory
3 Stocks Under $50 with Questionable Fundamentals
August 18, 2026
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...
Via
StockStory
3 Value Stocks We Steer Clear Of
August 17, 2026
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...
Via
StockStory
2 Russell 2000 Stocks with Solid Fundamentals and 1 We Find Risky
August 12, 2026
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...
Via
StockStory
Integra (IART) Q2 2026 Earnings Call Transcript
↗
August 07, 2026
Manufacturing restart and margin gains drive stabilization as company pursues deleveraging.
Via
The Motley Fool
Topics
Earnings
World Trade
5 Must-Read Analyst Questions From Integra LifeSciences’s Q2 Earnings Call
August 05, 2026
Integra LifeSciences’ second quarter results reflected ongoing business challenges, as management attributed the quarter’s flat revenue to ongoing reimbursem...
Via
StockStory
Topics
Earnings
World Trade
IART Q2 Deep Dive: Flat Revenue, Margin Pressure, and Operational Realignment Shape Outlook
July 30, 2026
Medical device company Integra LifeSciences (NASDAQ:IART) met Wall Street’s revenue expectations in Q2 CY2026, but sales were flat year on year at $418.8 mil...
Via
StockStory
Topics
World Trade
Why Integra LifeSciences (IART) Shares Are Sliding Today
July 29, 2026
What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) fell 10.1% in the afternoon session after the company reported a second-qu...
Via
StockStory
Topics
Earnings
Integra LifeSciences Q2 Earnings Call Highlights
↗
July 29, 2026
Integra LifeSciences (NASDAQ:IART) reported second-quarter 2026 revenue of $419 million, up 0.8% on a reported basis and 0.7% organically from a year earlier, as improving supply reliability and...
Via
MarketBeat
Topics
Earnings
World Trade
Integra LifeSciences’s (NASDAQ:IART) Q2 CY2026 Earnings Results: Revenue In Line With Expectations
July 29, 2026
Medical device company Integra LifeSciences (NASDAQ:IART) met Wall Street’s revenue expectations in Q2 CY2026, but sales were flat year on year at $418.8 mil...
Via
StockStory
Integra LifeSciences (IART) To Report Earnings Tomorrow: Here Is What To Expect
July 27, 2026
Medical device company Integra LifeSciences (NASDAQ:IART) will be announcing earnings results this Wednesday morning. Here’s what to look for. Integra LifeSc...
Via
StockStory
Topics
Artificial Intelligence
1 Healthcare Stock with Promising Prospects and 2 Facing Headwinds
July 24, 2026
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as...
Via
StockStory
Kaskela Law Firm Announces Investigation of Integra LifeSciences (IART) and Encourages Long-Term IART Shareholders with Investment Losses to Contact the Firm
July 23, 2026
From
Kaskela Law LLC
Via
Business Wire
3 Small-Cap Stocks with Warning Signs
July 17, 2026
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
Via
StockStory
Why Integra LifeSciences (IART) Stock Is Up Today
July 09, 2026
What Happened? Shares of medical device company Integra LifeSciences (NASDAQ:IART) jumped 4.3% in the afternoon session after BMO Capital initiated coverage ...
Via
StockStory
Topics
Artificial Intelligence
Earnings
3 Unpopular Stocks with Open Questions
June 29, 2026
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad t...
Via
StockStory
1 Value Stock to Target This Week and 2 We Brush Off
June 26, 2026
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...
Via
StockStory
Topics
Economy
Surgical Equipment & Consumables - Specialty Stocks Q1 Results: Benchmarking Integra LifeSciences (NASDAQ:IART)
June 22, 2026
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...
Via
StockStory
Topics
Artificial Intelligence
Economy
Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
June 18, 2026
From
Biotech Insider
Via
GlobeNewswire
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
June 16, 2026
From
World Street Intelligence
Via
GlobeNewswire
3 Profitable Stocks We’re Skeptical Of
June 15, 2026
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
